Marc Penn MD, PhD, FACC
Chief Executive Officer, OGH
Director of R&D, Okyanos
Renowned clinician, inventor and scientist, Dr. Penn founded the Cleveland Heart Lab (now part of Quest Diagnostics), and served as Director in cardiology posts with the Cleveland Clinic (2000-11) including the Coronary ICU, the Bakken Heart-Brain Institute and the Center for Cardiovascular Cell Therapy.
Vincent Burton MBBS, FRCA
President & Chief Anesthesiologist
Dr. Burton completed his residency training in the United Kingdom at Queen’s Hospital of Staffordshire, Norfolk and Norwich University Hospital as well as Addenbrooke’s Hospital Cambridge University. He is a Fellow of the Royal College of Anaesthetists (FRCA).
Dr. Warren Sherman, MD, FACC
Chief Medical Officer, OGH
Regenerative Medicine Specialist
Dr. Sherman is a renowned interventional cardiologist with an established focus in cell-based therapies who provides the highest level of care for patients with chronic heart failure and refractory angina.
Gretchen Dezelick, RN, BSN, CCRN, CNOR, LHCRM, CASC
Director of Nursing / Clinical Administrator
Gretchen Dezelick has more than 35 years of nursing experience progressing from bedside nursing to administrative and management positions in a variety of healthcare settings.
RK Khosla, MBA
Chief Business Officer, OGH
R.K. is an experienced C-level Biotech and Medtech Executive who has raised funds for ventures from inception through Phase I FIM and Phase IIb. He has expertise evaluating early stage technologies, as well as experience running revenue stage companies.